Tretinoin

• Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients Recruiting
  2023-507519-36-00 Phase III 1 country Centre Hospitalier Universitaire De Nice
• LYSARI – LYmphocyte-Sparing And Radio-Immunotherapy in Head and neck carcinoma - A multicenter, randomised 2*2 factorial design comparing st… Recruiting
  2022-501315-13-00 Phase III 3 countries Centre Leon Berard
• Pan-lesions SBRT combined with lymphocyte support through ATRA-driven blockade of MDSC in patients with oligometastatic solid cancer (LySATR… Recruiting
  2022-500680-13-00 Phase I/II 1 country Institut Gustave Roussy
• Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or … Recruiting
  2023-507461-26-00 Phase III 1 country Medical Center - University Of Freiburg
• ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia Ended
  2024-518669-83-00 Phase II 5 countries Associazione Italiana Ematologia Oncologia Pediatrica
• Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants with Melanoma (KEYMAK… Ended
  2023-506313-21-00 Phase I/II 6 countries Merck Sharp & Dohme LLC
• Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melano… Ended
  2023-506314-51-00 Phase I/II 2 countries Merck Sharp & Dohme LLC
• Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refracto… Ended
  2023-506312-41-00 Phase I/II 2 countries Merck Sharp & Dohme LLC

Showing 1–8 of 8 trials